TWI343825B - - Google Patents

Download PDF

Info

Publication number: TWI343825B
Authority: TW; Taiwan
Prior art keywords: drug; group; layer; controlled release; pharmaceutical composition
Prior art date: 2006-03-02

Application number

TW95106991A

Other languages

English (en)

Chinese (zh)

Other versions

TW200733987A (en

Inventor

Fang Hsiung Hsiao

Ya Ching Changchien

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-02

Filing date

2006-03-02

Publication date

2011-06-21

2006-03-02 Application filed filed Critical

2006-03-02 Priority to TW095106991A priority Critical patent/TW200733987A/zh

2007-09-16 Publication of TW200733987A publication Critical patent/TW200733987A/zh

2011-06-21 Application granted granted Critical

2011-06-21 Publication of TWI343825B publication Critical patent/TWI343825B/zh

Links

238000013270 controlled release Methods 0.000 claims description 65
239000003814 drug Substances 0.000 claims description 45
238000013268 sustained release Methods 0.000 claims description 42
239000012730 sustained-release form Substances 0.000 claims description 42
229940079593 drug Drugs 0.000 claims description 41
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 40
229960004688 venlafaxine Drugs 0.000 claims description 38
PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 claims description 38
-1 glycol diol Chemical class 0.000 claims description 34
239000008194 pharmaceutical composition Substances 0.000 claims description 34
239000001856 Ethyl cellulose Substances 0.000 claims description 30
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 30
235000019325 ethyl cellulose Nutrition 0.000 claims description 30
229920001249 ethyl cellulose Polymers 0.000 claims description 30
238000011068 loading method Methods 0.000 claims description 30
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 29
239000008187 granular material Substances 0.000 claims description 22
238000000034 method Methods 0.000 claims description 21
239000000203 mixture Substances 0.000 claims description 20
239000002253 acid Substances 0.000 claims description 19
239000004480 active ingredient Substances 0.000 claims description 19
239000002245 particle Substances 0.000 claims description 19
239000008188 pellet Substances 0.000 claims description 18
235000012222 talc Nutrition 0.000 claims description 18
239000000454 talc Substances 0.000 claims description 18
229910052623 talc Inorganic materials 0.000 claims description 18
239000004014 plasticizer Substances 0.000 claims description 17
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims description 16
238000004090 dissolution Methods 0.000 claims description 16
DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical group CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 15
235000010980 cellulose Nutrition 0.000 claims description 14
229920002678 cellulose Polymers 0.000 claims description 14
239000001913 cellulose Substances 0.000 claims description 14
239000001069 triethyl citrate Substances 0.000 claims description 14
VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 14
235000013769 triethyl citrate Nutrition 0.000 claims description 14
229920002472 Starch Polymers 0.000 claims description 13
239000003795 chemical substances by application Substances 0.000 claims description 13
239000011734 sodium Substances 0.000 claims description 13
239000008107 starch Substances 0.000 claims description 13
235000019698 starch Nutrition 0.000 claims description 13
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 12
ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 claims description 12
239000011248 coating agent Substances 0.000 claims description 12
238000000576 coating method Methods 0.000 claims description 12
229910052708 sodium Inorganic materials 0.000 claims description 12
239000002202 Polyethylene glycol Substances 0.000 claims description 11
239000000853 adhesive Substances 0.000 claims description 11
235000010443 alginic acid Nutrition 0.000 claims description 11
229920000615 alginic acid Polymers 0.000 claims description 11
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 11
229920001223 polyethylene glycol Polymers 0.000 claims description 11
239000004408 titanium dioxide Substances 0.000 claims description 11
FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 10
FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 10
235000011187 glycerol Nutrition 0.000 claims description 10
229920000168 Microcrystalline cellulose Polymers 0.000 claims description 9
235000021355 Stearic acid Nutrition 0.000 claims description 9
239000002552 dosage form Substances 0.000 claims description 9
229920000609 methyl cellulose Polymers 0.000 claims description 9
239000001923 methylcellulose Substances 0.000 claims description 9
235000010981 methylcellulose Nutrition 0.000 claims description 9
235000019813 microcrystalline cellulose Nutrition 0.000 claims description 9
239000008108 microcrystalline cellulose Substances 0.000 claims description 9
229940016286 microcrystalline cellulose Drugs 0.000 claims description 9
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 9
239000008117 stearic acid Substances 0.000 claims description 9
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 8
229940072056 alginate Drugs 0.000 claims description 8
230000000181 anti-adherent effect Effects 0.000 claims description 8
239000011230 binding agent Substances 0.000 claims description 8
229920001577 copolymer Polymers 0.000 claims description 8
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 6
239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 6
229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 6
229930195725 Mannitol Natural products 0.000 claims description 6
239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 6
235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 6
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical class OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 6
239000000594 mannitol Substances 0.000 claims description 6
235000010355 mannitol Nutrition 0.000 claims description 6
229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
239000005995 Aluminium silicate Substances 0.000 claims description 5
229920000858 Cyclodextrin Polymers 0.000 claims description 5
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
235000012211 aluminium silicate Nutrition 0.000 claims description 5
239000003085 diluting agent Substances 0.000 claims description 5
239000003937 drug carrier Substances 0.000 claims description 5
150000002148 esters Chemical class 0.000 claims description 5
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 5
239000008101 lactose Substances 0.000 claims description 5
239000000546 pharmaceutical excipient Substances 0.000 claims description 5
239000000049 pigment Substances 0.000 claims description 5
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 5
OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
108010010803 Gelatin Proteins 0.000 claims description 4
238000000889 atomisation Methods 0.000 claims description 4
238000005422 blasting Methods 0.000 claims description 4
LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
239000008273 gelatin Substances 0.000 claims description 4
229920000159 gelatin Polymers 0.000 claims description 4
235000019322 gelatine Nutrition 0.000 claims description 4
235000011852 gelatine desserts Nutrition 0.000 claims description 4
229940049654 glyceryl behenate Drugs 0.000 claims description 4
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 4
229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
239000000843 powder Substances 0.000 claims description 4
239000007921 spray Substances 0.000 claims description 4
JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 claims description 3
102000009123 Fibrin Human genes 0.000 claims description 3
108010073385 Fibrin Proteins 0.000 claims description 3
229930006000 Sucrose Natural products 0.000 claims description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
230000001070 adhesive effect Effects 0.000 claims description 3
239000000783 alginic acid Substances 0.000 claims description 3
229960001126 alginic acid Drugs 0.000 claims description 3
150000004781 alginic acids Chemical class 0.000 claims description 3
235000011132 calcium sulphate Nutrition 0.000 claims description 3
239000004359 castor oil Substances 0.000 claims description 3
235000019438 castor oil Nutrition 0.000 claims description 3
MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 claims description 3
229950003499 fibrin Drugs 0.000 claims description 3
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
229920003063 hydroxymethyl cellulose Polymers 0.000 claims description 3
229940031574 hydroxymethyl cellulose Drugs 0.000 claims description 3
239000001488 sodium phosphate Substances 0.000 claims description 3
229940045902 sodium stearyl fumarate Drugs 0.000 claims description 3
239000005720 sucrose Substances 0.000 claims description 3
ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 claims description 3
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
229910000406 trisodium phosphate Inorganic materials 0.000 claims description 3
235000019801 trisodium phosphate Nutrition 0.000 claims description 3
229920001285 xanthan gum Polymers 0.000 claims description 3
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 2
239000007771 core particle Substances 0.000 claims description 2
235000019700 dicalcium phosphate Nutrition 0.000 claims description 2
238000010790 dilution Methods 0.000 claims description 2
239000012895 dilution Substances 0.000 claims description 2
238000002309 gasification Methods 0.000 claims description 2
230000002934 lysing effect Effects 0.000 claims description 2
235000015424 sodium Nutrition 0.000 claims description 2
125000000185 sucrose group Chemical group 0.000 claims description 2
235000010215 titanium dioxide Nutrition 0.000 claims description 2
238000005550 wet granulation Methods 0.000 claims description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
229940032147 starch Drugs 0.000 claims 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 2
229920001800 Shellac Polymers 0.000 claims 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
229960000829 kaolin Drugs 0.000 claims 2
239000004208 shellac Substances 0.000 claims 2
229940113147 shellac Drugs 0.000 claims 2
ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims 2
235000013874 shellac Nutrition 0.000 claims 2
KKMOSYLWYLMHAL-UHFFFAOYSA-N 2-bromo-6-nitroaniline Chemical compound NC1=C(Br)C=CC=C1[N+]([O-])=O KKMOSYLWYLMHAL-UHFFFAOYSA-N 0.000 claims 1
GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 1
241000747049 Aceros Species 0.000 claims 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
OLMVUHDZRAAOGQ-UHFFFAOYSA-N C(C=C)(=O)OS.C(C=C)(=O)O Chemical compound C(C=C)(=O)OS.C(C=C)(=O)O OLMVUHDZRAAOGQ-UHFFFAOYSA-N 0.000 claims 1
BLRHNAZXNFXKNB-UHFFFAOYSA-N C(CC(O)(C(=O)OCCCC)CC(=O)OCCCC)(=O)OCC Chemical compound C(CC(O)(C(=O)OCCCC)CC(=O)OCCCC)(=O)OCC BLRHNAZXNFXKNB-UHFFFAOYSA-N 0.000 claims 1
235000008733 Citrus aurantifolia Nutrition 0.000 claims 1
241000218176 Corydalis Species 0.000 claims 1
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 claims 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
235000011941 Tilia x europaea Nutrition 0.000 claims 1
ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 claims 1
229930013930 alkaloid Natural products 0.000 claims 1
239000008119 colloidal silica Substances 0.000 claims 1
239000011521 glass Substances 0.000 claims 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
229960003299 ketamine Drugs 0.000 claims 1
239000004571 lime Substances 0.000 claims 1
NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 claims 1
229910000105 potassium hydride Inorganic materials 0.000 claims 1
239000008159 sesame oil Substances 0.000 claims 1
235000011803 sesame oil Nutrition 0.000 claims 1
229940080313 sodium starch Drugs 0.000 claims 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
239000000052 vinegar Substances 0.000 claims 1
235000021419 vinegar Nutrition 0.000 claims 1
239000011162 core material Substances 0.000 description 46
QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical class [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 description 25
229960002416 venlafaxine hydrochloride Drugs 0.000 description 23
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
239000000243 solution Substances 0.000 description 17
230000000694 effects Effects 0.000 description 14
238000002360 preparation method Methods 0.000 description 13
239000008280 blood Substances 0.000 description 8
210000004369 blood Anatomy 0.000 description 8
239000000725 suspension Substances 0.000 description 8
238000011282 treatment Methods 0.000 description 7
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 6
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
239000007864 aqueous solution Substances 0.000 description 5
239000002775 capsule Substances 0.000 description 5
239000000835 fiber Substances 0.000 description 5
239000007888 film coating Substances 0.000 description 5
238000009501 film coating Methods 0.000 description 5
239000013022 formulation composition Substances 0.000 description 5
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
150000001875 compounds Chemical class 0.000 description 4
239000007788 liquid Substances 0.000 description 4
239000003826 tablet Substances 0.000 description 4
206010028813 Nausea Diseases 0.000 description 3
238000009472 formulation Methods 0.000 description 3
239000000499 gel Substances 0.000 description 3
239000007903 gelatin capsule Substances 0.000 description 3
238000002156 mixing Methods 0.000 description 3
230000008693 nausea Effects 0.000 description 3
230000008569 process Effects 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
230000002459 sustained effect Effects 0.000 description 3
238000012546 transfer Methods 0.000 description 3
RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 2
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
235000005979 Citrus limon Nutrition 0.000 description 2
244000131522 Citrus pyriformis Species 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
206010047700 Vomiting Diseases 0.000 description 2
TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
229940116224 behenate Drugs 0.000 description 2
UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 2
QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
229910000420 cerium oxide Inorganic materials 0.000 description 2
238000007922 dissolution test Methods 0.000 description 2
UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
238000001035 drying Methods 0.000 description 2
238000005538 encapsulation Methods 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
238000001125 extrusion Methods 0.000 description 2
238000011049 filling Methods 0.000 description 2
229960002464 fluoxetine Drugs 0.000 description 2
229960004038 fluvoxamine Drugs 0.000 description 2
CJOFXWAVKWHTFT-XSFVSMFZSA-N fluvoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(C(F)(F)F)C=C1 CJOFXWAVKWHTFT-XSFVSMFZSA-N 0.000 description 2
238000005469 granulation Methods 0.000 description 2
230000003179 granulation Effects 0.000 description 2
239000000017 hydrogel Substances 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
230000001788 irregular Effects 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 2
229940100467 polyvinyl acetate phthalate Drugs 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
230000000697 serotonin reuptake Effects 0.000 description 2
239000002904 solvent Substances 0.000 description 2
241000894007 species Species 0.000 description 2
238000005507 spraying Methods 0.000 description 2
OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
230000008673 vomiting Effects 0.000 description 2
235000010493 xanthan gum Nutrition 0.000 description 2
239000000230 xanthan gum Substances 0.000 description 2
229940082509 xanthan gum Drugs 0.000 description 2
AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-L 2-(carboxymethyl)-2-hydroxysuccinate Chemical compound [O-]C(=O)CC(O)(C(=O)O)CC([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-L 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
WBKYGCZSBGEBFP-UHFFFAOYSA-N 5-butoxy-3-butoxycarbonyl-3-hydroxy-5-oxopentanoic acid Chemical compound CCCCOC(=O)CC(O)(CC(O)=O)C(=O)OCCCC WBKYGCZSBGEBFP-UHFFFAOYSA-N 0.000 description 1
RWHRFHQRVDUPIK-UHFFFAOYSA-N 50867-57-7 Chemical compound CC(=C)C(O)=O.CC(=C)C(O)=O RWHRFHQRVDUPIK-UHFFFAOYSA-N 0.000 description 1
235000021357 Behenic acid Nutrition 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
NDXPHDHLPPOUQI-UHFFFAOYSA-N C(CC(O)(C(=O)O)CC(=O)O)(=O)O.C(CCC)NN Chemical compound C(CC(O)(C(=O)O)CC(=O)O)(=O)O.C(CCC)NN NDXPHDHLPPOUQI-UHFFFAOYSA-N 0.000 description 1
239000005944 Chlorpyrifos Substances 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
208000020401 Depressive disease Diseases 0.000 description 1
229920003163 Eudragit® NE 30 D Polymers 0.000 description 1
241000257303 Hymenoptera Species 0.000 description 1
239000005639 Lauric acid Substances 0.000 description 1
240000005373 Panax quinquefolius Species 0.000 description 1
235000003140 Panax quinquefolius Nutrition 0.000 description 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 1
102000016941 Rho Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
108010053823 Rho Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
239000004115 Sodium Silicate Substances 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
OOIOHEBTXPTBBE-UHFFFAOYSA-N [Na].[Fe] Chemical compound [Na].[Fe] OOIOHEBTXPTBBE-UHFFFAOYSA-N 0.000 description 1
206010000059 abdominal discomfort Diseases 0.000 description 1
229920006221 acetate fiber Polymers 0.000 description 1
230000009471 action Effects 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000000935 antidepressant agent Substances 0.000 description 1
229940116226 behenic acid Drugs 0.000 description 1
229940007550 benzyl acetate Drugs 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000001175 calcium sulphate Substances 0.000 description 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 1
229910000422 cerium(IV) oxide Inorganic materials 0.000 description 1
SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 1
239000007891 compressed tablet Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
HFNCOTSLOKKPHU-UHFFFAOYSA-N cyclohexanol;hydrochloride Chemical compound Cl.OC1CCCCC1 HFNCOTSLOKKPHU-UHFFFAOYSA-N 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
239000003405 delayed action preparation Substances 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
150000002009 diols Chemical class 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
235000013305 food Nutrition 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
239000010460 hemp oil Substances 0.000 description 1
229940127022 high-dose drug Drugs 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
150000003840 hydrochlorides Chemical class 0.000 description 1
229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
239000012729 immediate-release (IR) formulation Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
238000011418 maintenance treatment Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
230000000966 norepinephrine reuptake Effects 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
229960002296 paroxetine Drugs 0.000 description 1
IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
229920002744 polyvinyl acetate phthalate Polymers 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
AMCPECLBZPXAPB-UHFFFAOYSA-N propane-1,2,3-triol;sodium Chemical compound [Na].OCC(O)CO AMCPECLBZPXAPB-UHFFFAOYSA-N 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
239000001397 quillaja saponaria molina bark Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
229940124834 selective serotonin reuptake inhibitor Drugs 0.000 description 1
229960002073 sertraline Drugs 0.000 description 1
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
208000019116 sleep disease Diseases 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
229910052911 sodium silicate Inorganic materials 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
YALHCTUQSQRCSX-UHFFFAOYSA-N sulfane sulfuric acid Chemical compound S.OS(O)(=O)=O YALHCTUQSQRCSX-UHFFFAOYSA-N 0.000 description 1
PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000007939 sustained release tablet Substances 0.000 description 1
XRCRWCVBMHENNE-UHFFFAOYSA-N sym-di-n-butyl citrate Natural products CCCCOC(=O)CC(O)(C(O)=O)CC(=O)OCCCC XRCRWCVBMHENNE-UHFFFAOYSA-N 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000010998 test method Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000011287 therapeutic dose Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical class [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 description 1

Landscapes

Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

TW095106991A 2006-03-02 2006-03-02 Medicinal composition containing venlafaxine and the manufacturing method thereof TW200733987A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
TW095106991A TW200733987A (en)	2006-03-02	2006-03-02	Medicinal composition containing venlafaxine and the manufacturing method thereof

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
TW095106991A TW200733987A (en)	2006-03-02	2006-03-02	Medicinal composition containing venlafaxine and the manufacturing method thereof

Publications (2)

Publication Number	Publication Date
TW200733987A TW200733987A (en)	2007-09-16
TWI343825B true TWI343825B (fr)	2011-06-21

Family

ID=45074898

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095106991A TW200733987A (en)	2006-03-02	2006-03-02	Medicinal composition containing venlafaxine and the manufacturing method thereof

Country Status (1)

Country	Link
TW (1)	TW200733987A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN114699512B (zh) *	2022-04-02	2024-05-28	贵州医科大学	一种甲状旁腺激素缓释药物及其制备方法

2006
- 2006-03-02 TW TW095106991A patent/TW200733987A/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
TW200733987A (en)	2007-09-16

Legal Events

Date	Code	Title	Description
2023-03-21	MM4A	Annulment or lapse of patent due to non-payment of fees

Publication	Publication Date	Title
JP5607670B2 (ja)	2014-10-15	時限拍動性薬物送達システム
JP4789806B2 (ja)	2011-10-12	パントプラゾール多粒子処方
US20050152967A1 (en)	2005-07-14	Dynamic variable release
US20100047343A1 (en)	2010-02-25	Multiparticulate formulation having tramadol in immediate and controlled release form
CN103315965A (zh)	2013-09-25	一种适用于婴幼儿及儿童的口服固体颗粒及其制备方法
AU2003288604A1 (en)	2004-07-14	Controlled release pharmaceutical compositions of tamsulosin
CN107205950A (zh)	2017-09-26	金刚烷胺组合物的施用方法
CN1161112C (zh)	2004-08-11	含氯雷他定和伪麻黄碱的药物胶囊组合物
WO2014040548A1 (fr)	2014-03-20	Médicament de métoprolol à libération prolongée et procédé de préparation de celui-ci
EP2599477A1 (fr)	2013-06-05	Formulation à libération prolongée d'acide 4-phénylbutyrique
CN104922078B (zh)	2018-10-23	非诺贝特迟释微丸、制备方法及应用
CN100581540C (zh)	2010-01-20	单硝酸异山梨酯定时速释缓释制剂
US10517829B2 (en)	2019-12-31	Extended release pharmaceutical compositions
WO2003015758A1 (fr)	2003-02-27	Micro-pastilles a liberation prolongee et procede permettant leur production
CN101829070A (zh)	2010-09-15	一种克拉霉素缓释分散片及其制备方法
AU2003257425A1 (en)	2004-01-19	Spherical pellet containing a water-soluble active ingredient
CN114748443A (zh)	2022-07-15	一种盐酸美金刚缓释微丸及其制备方法
EP0896530B1 (fr)	2002-06-26	Formes galeniques et leurs utilisations
JPH02501744A (ja)	1990-06-14	ブスピロンおよびその塩の経口投与用組成物
JP2023510223A (ja)	2023-03-13	徐放性メラトニンペレットを含む剤形
US8313766B2 (en)	2012-11-20	Oral antidepressant formulation with reduced excipient load
EP3432865B1 (fr)	2021-05-19	Forme pharmaceutique orale
JP5919173B2 (ja)	2016-05-18	徐放性塩酸アンブロキソール口腔内崩壊錠
CN101057837B (zh)	2010-12-22	一种右旋酮洛芬肠溶微丸及制备方法
Sonawane et al.	2016	Formulation aspects and effect of critical factors for designing extended release pellets: an updated review